Pillar
Pharma Marketing
-
Six Decisions Decide Your Launch. The First One Is Due Two Years Out.
Across 19 first-time launchers, the gap between naming a commercial owner and FDA approval ran from 12 months to 98. There is no convention, only a sequence.
-
What Launch Orchestration Actually Looks Like at Multi-Market Scale
Most teams running multi-market launch think the hard problem is localization. It is not. The hard part is orchestration: building an operating model eleven markets can actually run while still producing one brand. Six elements make it work, and most teams only build two.
-
AI Is Not a Tool. It Is an Operating Layer.
Most pharma teams are using AI. Fewer have made it part of how their commercial operation actually runs. That distinction is structural, not philosophical. Here is what it looked like when I built it at Novartis.